Tnf-alpha antagonist and other biotherapy (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
46 | Malignant rheumatoid arthritis | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02886689 (ClinicalTrials.gov) | January 2007 | 29/8/2016 | C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France | C.O.R.P.U.S. : Observational Cohort of Active Rheumatoid Arthritis, Spondylarthropathy and Idiopathic Juvenile Arthritis in France | Arthritis, Rheumatoid;Spondylitis, Ankylosing;Arthritis, Psoriatic;Arthitis, Juvenile Idiopathic | Drug: TNF-alpha antagonist and other biotherapy | Central Hospital, Nancy, France | NULL | Completed | 3 Years | 75 Years | Both | 5400 | N/A | France |